Stay updated with breaking news from Zyme Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Establishment of Optibrium Inc. bolsters ongoing strategic Company growth and strengthens direct US customer support Dr Tamsin Mansley promoted to President of Optibrium Inc. to lead growing
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer and pre|CISION platforms, announces that the US Food and Drug
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer and pre|CISION platforms, announces that the first-in-human
Press release content from Business Wire. The AP news staff was not involved in its creation.
Dr Jennifer Schneider appointed CEO, Dr Helen Bright joins as VP of Research Development, and Professor David Roblin will Chair the Board of Directors Senior appointments support acceleration